The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.
October 31st 2024
T-VASI and F-VASI are validated, responsive tools for assessing vitiligo severity and re-pigmentation, with meaningful change thresholds established.
Patients With Vitiligo, End-Stage Renal Disease Face Greater Risk of Infection
January 30th 2024Vitiligo was significantly associated with an increased risk of bacteremia, cellulitis, and herpes zoster and was more common among those with female sex, Black compared to White race, Hispanic ethnicity, hepatitis C infection, and tobacco use.
FDA Adverse Events Reporting System Shows Rise in Alopecia Cases, Use of Monoclonal Antibodies
These data represent a significant step toward finding a causal connection for drug-induced alopecia, though further controlled studies may be necessary to isolate certain variables.
Climate Change and Eczema: Spotlighting Hazards, Trends, Gaps in Awareness
This study contributes to existing climate change data by exploring climatic hazards and their relationship with atopic dermatitis, in addition to highlighting research gaps and future predictions.
James Q. Del Rosso, DO: What's New for Acne, Rosacea, Psoriasis, Other Common Dermatoses
In this interview, Del Rosso spoke on takeaways from his conference talk ‘What's New in the Medicine Chest? Acne, Rosacea, Actinic Keratoses, Psoriasis, Urticaria and Other Common Dermatoses.’
Long-Term Efficacy of Risankizumab Observed for Psoriasis Regardless of Disease Characteristics
These data indicate a significant ability of this treatment to address patients’ psoriatic symptoms in a comprehensive manner, despite varying characteristics and demographics.